Phreesia, Inc. (NYSE:PHR – Get Free Report) SVP David Linetsky sold 11,685 shares of the business’s stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $321,103.80. Following the transaction, the senior vice president now directly owns 231,271 shares in the company, valued at $6,355,327.08. The trade was a 4.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
David Linetsky also recently made the following trade(s):
- On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The stock was sold at an average price of $25.38, for a total transaction of $609.12.
- On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The shares were sold at an average price of $24.88, for a total transaction of $870.80.
- On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The shares were sold at an average price of $24.85, for a total value of $294,547.05.
Phreesia Price Performance
Shares of NYSE:PHR opened at $28.81 on Thursday. The company has a market cap of $1.67 billion, a price-to-earnings ratio of -19.60 and a beta of 0.94. The business has a 50 day moving average price of $24.57 and a 200 day moving average price of $23.20. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.90.
Wall Street Analysts Forecast Growth
PHR has been the subject of a number of recent research reports. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a research report on Wednesday. Truist Financial increased their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Thirteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $31.15.
Read Our Latest Stock Analysis on Phreesia
Institutional Trading of Phreesia
Several hedge funds and other institutional investors have recently bought and sold shares of PHR. R Squared Ltd bought a new stake in shares of Phreesia in the fourth quarter valued at about $30,000. Wesbanco Bank Inc. raised its holdings in Phreesia by 76.9% in the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after acquiring an additional 20,000 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after acquiring an additional 42,973 shares during the period. Geode Capital Management LLC grew its holdings in shares of Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. Finally, M&T Bank Corp increased its position in shares of Phreesia by 4.6% during the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock valued at $801,000 after purchasing an additional 1,535 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.
Phreesia Company Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Featured Articles
- Five stocks we like better than Phreesia
- ETF Screener: Uses and Step-by-Step Guide
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- What Are Dividends? Buy the Best Dividend Stocks
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Insider Trading – What You Need to Know
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.